Scientists of the Fraunhofer Institute for Biomedical Engineering IBMT in Sulzbach/Saar and the Fraunhofer EMFT on the campus of the University of Regensburg are working together with the companies nanoAnalytics GmbH (Münster) and innoMe GmbH (Espelkamp) on a new measuring method for testing the effectiveness of vaccines.
For this purpose, the test cells are placed on multi-electrode arrays, which allow their infection status to be recorded completely automatically applying electrochemical measuring methods. This replaces the costly staining reactions of conventional tests, which saves time and money.
Another advantage of the new method is that the cells are continuously monitored over the entire incubation period. With the previously used staining methods, they are only analysed at a specific endpoint in time. This provides the researchers with additional information on the time course of the cell reaction that was previously not available. The consortium is aiming for a complete system, including the measuring device, the associated analysis software and the electrode arrays required for cell observation, and implementing it in laboratory set-ups that will pave the way for a later market launch.
The „ViroSens“ project is funded by the Federal Ministry of Education and Research (BMBF) under the KMUinnovativ funding guideline with a total amount of around €2 million.